Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 12—December 2022
Research Letter

Severe Human Case of Zoonotic Infection with Swine-Origin Influenza A Virus, Denmark, 2021

Author affiliations: Technical University of Denmark, Kongens Lyngby, Denmark (K.M. Andersen); Statens Serum Institut, Copenhagen, Denmark (K.M. Andersen, L.S. Vestergaard, J.N. Nissen, C.K. Hjulsager, J.S. Krog, S. Alexandersen, R. Trebbien); University of Copenhagen, Copenhagen (S.J. George, P. Ryt-Hansen, L.E. Larsen); Odense University Hospital, Odense, Denmark (M.N. Skov)

Cite This Article

Abstract

During routine surveillance at the National Influenza Center, Denmark, we detected a zoonotic swine influenza A virus in a patient who became severely ill. We describe the clinical picture and the genetic characterization of this variant virus, which is distinct from another variant found previously in Denmark.

Human infections with swine influenza A viruses (IAVs) are sporadically reported (14). Increased surveillance has revealed substantial swine IAV circulation within pig herds and frequent reassortment with human seasonal IAVs (5). Despite no sustained human-to-human transmission of variant IAV cases since the 2009 influenza A(H1N1) pandemic, the zoonotic potential is of concern. We report a case of human infection with a swine-origin IAV that resulted in severe illness in a younger, otherwise healthy person employed at a swine slaughterhouse in Denmark. This case was detected 10 months after our previously reported case (4). The patient provided informed consent for publication of this case report.

On November 24, 2021, a person of ≈50 years of age was hospitalized after acute onset of illness characterized by dizziness on the night of November 23, 2021, followed by chest pain, pain radiating toward the left arm, diarrhea, and malaise that developed the next morning, but no fever. The patient called for emergency medical assistance, which arrived shortly. During ambulance transportation and at hospital arrival, the patient experienced repeated convulsions and was admitted to the intensive care unit and put on mechanical ventilation to manage seizures and associated reduced oxygen level. Extensive clinical examination, such as laboratory investigations (i.e., biochemical, microbiological, and immunological assays), multiorgan radiological examinations, and electroencephalography (Appendix 1), identified no cardiovascular, renal, neurologic, or other diseases that could explain the sudden severe illness. However, a tracheal sample collected and analyzed at the local microbiology laboratory was found positive for IAV (Appendix 1). No other microbiological agents were detected, including SARS-CoV-2 or other respiratory viruses, and the patient showed no signs of pneumonia. The patient received antiviral medication (oseltamivir) and various supportive treatments, and over the next 2 days the clinical condition improved; the patient was soon after discharged from the hospital.

Figure

Maximum-likelihood phylogenetic tree of the hemagglutinin gene of influenza A virus from a patient in Denmark (A/Denmark/36/2021), the seasonal vaccine strain, and closely related strains. The tree includes the case variant virus A/Denmark/36/2021 (red), the 10 closest BLAST matches (https://blast.ncbi.nlm.nih.gov/Blast.cgi), the previously reported Denmark variant virus A/Denmark/1/2021 (green), human seasonal reference viruses with >85% nucleotide identity to A/Denmark/36/2021 (Appendix 2 Table), and representative viruses from the passive surveillance program of influenza viruses in pigs from Denmark. The tree is rooted on A/California/07/2009. Human IAV sequences are shown in blue, and most seasonal reference viruses have been collapsed. Scale bar indicates nucleotide substitutions per site.

Figure. Maximum-likelihood phylogenetic tree of the hemagglutinin gene of influenza A virus from a patient in Denmark (A/Denmark/36/2021), the seasonal vaccine strain, and closely related strains. The tree includes the case...

The remaining sample material was submitted to the Danish National Influenza Center as part of routine influenza surveillance. The sample was confirmed positive for the pandemic H1N1 strain and was further analyzed by whole-genome sequencing (Appendix 1). Consensus sequences for the virus named A/Denmark/36/2021 were uploaded to GISAID (https://www.gisaid.org; isolate no. EPI_ISL_8786194). WGS confirmed the H1N1 subtype; however, the virus had closer similarity to swine IAVs (Figure) than to other human strains. BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) searches revealed no close matches to IAV sequences in GenBank or GISAID, but comparison to in-house sequences from the passive surveillance of influenza viruses in pigs from Denmark revealed close similarity to 2021 swine IAVs (Table). Phylogenetic analyses showed that most gene segments were related to the pandemic H1N1 subtype (clade 1A3.3.2), whereas the neuraminidase and nonstructural segments belonged to the clade 1C Eurasian avian-like swine influenza A(H1N1) (Figure; Appendix 1 Figures 1–7). In contrast, another variant virus found recently in Denmark had a clade 1C nonstructural segment, whereas the 7 other gene segments were related to clade 1A3.3.2 pandemic H1N1 viruses (4).

In-depth interviews with the patient revealed occupational exposure to swine in a pig slaughterhouse in Denmark, which appears the most likely place of infection. The patient handled live pigs, carcasses, and meat during the slaughtering process while wearing protective equipment including gloves and gown but no face mask. The patient was previously healthy, had no underlying diseases or immune deficiencies, and had received the recommended quadrivalent seasonal influenza vaccine in October 2021.

No other cases of influenza had been reported at the patient’s workplace or among close contacts. In the 2021–22 influenza season, 16,160 cases of influenza A virus occurred among 244,184 tested samples in Denmark; the H3N2 subtype was dominant. No other human cases of swine-origin influenza virus were detected during this period. Genetic analyses and antigenic characterization of the virus (Appendix 1 Table 1, Figure 8) showed several genetic and antigenic differences and suggested poor reactivity to the contemporary human seasonal influenza vaccine.

This reported case is considered independent of the previously reported variant infection in Denmark (4), because the 2 viruses are genetically distinct (Table). The symptoms were also different; the earlier case was in an elderly patient with comorbidities who experienced classical influenza-like illness, but in this case, a previously healthy adult of younger age experienced unusual severe and sudden illness. Influenza-associated convulsions in adults are rare (6) and mostly accompanied by fever or encephalitis, which was not observed in this patient.

The identification of variant IAVs emphasizes the zoonotic potential of these strains and highlights the importance of continued monitoring of both human and swine IAVs. The reported case suggests a need for focusing on early registration of swine exposure for humans with influenza-like illness, as well as increased measures to reduce the swine IAV exposure risk for people with occupational contact with swine.

Ms. Andersen is a PhD student at the Department of Health Technology, Technical University of Denmark and at the National Influenza Center, Statens Serum Institut, Denmark. Her research interests are the genetic evolution of influenza A viruses at the human/swine interface and using bioinformatics to identify genetic markers of zoonotic transmission.

Top

Acknowledgments

We thank the laboratory technicians from the National Influenza Center at Statens Serum Institute for technical assistance in the laboratory. We also thank the patient for collaboration through the interviews and for allowing publication of the case.

This work has been conducted as part of the national influenza surveillance in Denmark, which is funded by the government, and as part of the FluZooMark project, funded by the Novo Nordisk Foundation (grant no. NNF19OC0056326).

Top

References

  1. Freidl  GS, Meijer  A, de Bruin  E, de Nardi  M, Munoz  O, Capua  I, et al.; FLURISK Consortium. Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill. 2014;19:20793. DOIPubMedGoogle Scholar
  2. Parys  A, Vandoorn  E, King  J, Graaf  A, Pohlmann  A, Beer  M, et al. Human infection with Eurasian avian-like swine influenza A(H1N1) virus, the Netherlands, September 2019. Emerg Infect Dis. 2021;27:93943. DOIPubMedGoogle Scholar
  3. Dürrwald  R, Wedde  M, Biere  B, Oh  DY, Heßler-Klee  M, Geidel  C, et al. Zoonotic infection with swine A/H1avN1 influenza virus in a child, Germany, June 2020. Euro Surveill. 2020;25:2001638. DOIPubMedGoogle Scholar
  4. Nissen  JN, George  SJ, Hjulsager  CK, Krog  JS, Nielsen  XC, Madsen  TV, et al. Reassortant influenza A(H1N1)pdm09 virus in elderly woman, Denmark, January 2021. Emerg Infect Dis. 2021;27:32025. DOIPubMedGoogle Scholar
  5. Ryt-Hansen  P, Krog  JS, Breum  , Hjulsager  CK, Pedersen  AG, Trebbien  R, et al. Co-circulation of multiple influenza A reassortants in swine harboring genes from seasonal human and swine influenza viruses. eLife. 2021;10:10. DOIPubMedGoogle Scholar
  6. Ruisanchez-Nieva  A, Martinez-Arroyo  A, Gomez-Beldarrain  M, Bocos Portillo  J, Garcia-Monco  JC. Influenza-associated seizures in healthy adults: Report of 3 cases. Epilepsy Behav Case Rep. 2017;8:123. DOIPubMedGoogle Scholar

Top

Figure
Table

Top

Cite This Article

DOI: 10.3201/eid2812.220935

Original Publication Date: November 16, 2022

Table of Contents – Volume 28, Number 12—December 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Klara Marie Andersen, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark

Send To

10000 character(s) remaining.

Top

Page created: October 21, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external